Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trialsNonhlanhla N. Mkhize, Lynn Morris, David Matten et al.|PLoS Pathogens|2023Cited by 57
Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIVNonhlanhla N. Mkhize, Sinead Delany‐Moretlwe, Bo Zhang et al.|Nature Communications|2025Cited by 1
Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trialsNyaradzo Mgodi, Allan C. deCamp, John Hural et al.|UNC Libraries|2023Cited by 0